AWM
MRNA icon

AE Wealth Management’s Moderna MRNA Stock Holding History

AE Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,117
Closed -$419K – 1675
2023
Q4 		$419K Sell
4,117
-1,030
-20% -$86.6K ﹤0.01% 1544
2023
Q3 		$532K Sell
5,147
-1,574
-23% -$176K ﹤0.01% 1344
2023
Q2 		$817K Buy
6,721
+922
+16% +$123K ﹤0.01% 1163
2023
Q1 		$891K Buy
5,799
+179
+3% +$29.5K 0.01% 1095
2022
Q4 		$1.01M Sell
5,620
-5,579
-50% -$912K 0.01% 980
2022
Q3 		$1.32M Buy
11,199
+2,022
+22% +$307K 0.01% 839
2022
Q2 		$1.31M Buy
9,177
+841
+10% +$120K 0.01% 801
2022
Q1 		$1.44M Buy
8,336
+497
+6% +$83.7K 0.01% 801
2021
Q4 		$1.99M Sell
7,839
-2,988
-28% -$874K 0.01% 701
2021
Q3 		$4.17M Buy
10,827
+2,631
+32% +$970K 0.03% 424
2021
Q2 		$1.93M Buy
8,196
+668
+9% +$119K 0.02% 650
2021
Q1 		$986K Sell
7,528
-1,479
-16% -$214K 0.01% 771
2020
Q4 		$941K Buy
9,007
+991
+12% +$100K 0.01% 727
2020
Q3 		$567K Buy
8,016
+1,144
+17% +$79.8K 0.01% 838
2020
Q2 		$441K Buy
+6,872
New +$376K 0.01% 918

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AE Wealth Management's MRNA Position: Q1 2024 in Review

AE Wealth Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 4,117 shares — an estimated $419K sold.

AE Wealth Management first reported a position in MRNA in Q2 2020 and held it in 15 quarters. The position peaked at $4.17M in Q3 2021. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • AE Wealth Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • AE Wealth Management sold 4,117 Moderna shares in Q1 2024, an estimated $419K.
  • AE Wealth Management first reported a position in Moderna in Q2 2020 and held it in 15 quarters.
  • AE Wealth Management's Moderna position peaked at $4.17M in Q3 2021.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on AE Wealth Management's 13F filing for Q1 2024, filed 15 May 2024.